MariMed Inc. (MRMD)
OTCQX OTCQX Primary 
CNSX 
MariMed Inc. (MRMD) Q3 2024 Earnings Call Transcript
MariMed Inc. (OTCQX:MRMD) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Steve West - Vice President, Investor Relations Jon Levine - Chief Executive Officer Ryan Crandall - Chief Revenue Officer Tim Shaw - Chief Operating Officer Mario Pinho - Chief Financial Officer Conference Call Participants Pablo Zuanic - Zuanic Associates Andrew Semple - Ventum Financial Jesse Redmond - Water Tower Research William McNarland - TDR Research Operator Good morning. My name is Nicole, and I will be your lead operator for today.
Can MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?
In Zuanic & Associates' latest equity report, senior analyst Pablo Zuanic analyzes MariMed's MRMD performance across its core markets, with Illinois (IL) accounting for 40-45% of the company's sales.
MariMed succeeds with growth strategy prioritizing conservatism over quick wins
MariMed (OTCQX:MRMD) has captured opportunities across the cannabis value chain with its “seed-to-sale” approach, encompassing flower cultivation, product development, marketing and distribution, and retail operations in key cannabis growth markets in the US. Importantly, the company chose a deliberate and evenly paced approach over the lure of rapid expansion to reach this point.
